Translating into Русский. The English version is shown until it is ready.
Korea pharma association to hold global clinical R&D seminar on Oct 16
Коротко
The Korea Pharmaceutical and Bio-Pharma Association said on Oct 6 it will hold a seminar on strengthening research and development capabilities for global clinical trials on Oct 16 at its offices, Yonhap reported. The programme covers global clinical trial design strategies and trends and shares clinical trial regulations by region and country. Newsis headlined the same event as covering R&D, clinical trials and regulatory-affairs capability building.
Читать полностью 1 мин чтения
The Korea Pharmaceutical and Bio-Pharma Association said on Oct 6 that it will hold a seminar on strengthening research and development capabilities for global clinical trials, Yonhap reported. The event is scheduled for Oct 16 at the association's offices, the agency said, adding that the programme will cover global clinical trial design strategies and trends and share clinical trial regulations by region and country. [ 2 ]
Newsis also reported the association's plan to hold the seminar, headlining it as covering R&D, clinical trials and regulatory-affairs (RA) capability strengthening. Yonhap's brief framed the session around R&D and clinical trial content, listing regulatory information as material to be shared rather than a separate track. [ 1 , 2 ]
Neither outlet gave an agenda, speakers or expected attendance for the event. Newsis's headline was the only part of its report about the seminar; the article text beneath it discussed a Supreme Court hearing instead. Yonhap's mention came inside a roundup of pharmaceutical and bio industry briefs. [ 1 , 2 ]
Почему это важно
The seminar points to continued industry effort in Korea to prepare companies for overseas clinical trials, including regulatory requirements in different regions. Beyond the association's own announcement, the documents give no indication of how large the event is or what it will change, so its significance remains limited to industry training.
Ключевые факты
- The Korea Pharmaceutical and Bio-Pharma Association announced on Oct 6 that it will hold a seminar on strengthening R&D capabilities for global clinical trials, Yonhap reported. [ 2 ]
- The seminar is scheduled for Oct 16 at the association's offices, according to Yonhap. [ 2 ]
- The agenda includes global clinical trial design strategies and trends. [ 2 ]
- The seminar will share clinical trial regulations by region and country. [ 2 ]
- Newsis headlined the event as covering R&D, clinical trials and regulatory-affairs (RA) capability strengthening. [ 1 ]
- Yonhap's report appeared as one item in a roundup of pharmaceutical and bio industry briefs. [ 2 ]
Подтверждено несколькими источниками
Пока неясно
- Whether the seminar includes a separate regulatory-affairs (RA) track, as Newsis's headline states, or only shares regulatory information as part of the clinical programme, as Yonhap describes. The two documents frame the scope differently; Newsis's headline mentions RA explicitly while Yonhap's brief lists R&D and clinical trial content.
- The seminar's speakers, detailed agenda, expected attendance and how companies can take part. Neither document states any of these details.
- The content of Newsis's report, because the article text under its seminar headline discusses a Supreme Court hearing rather than the seminar. The only Newsis material about the seminar is its headline and title, so no further detail from that outlet can be used.
Что пишут местные СМИ
Хронология, местное время
- Newsis publishes a report headlined on the association's R&D, clinical trials and regulatory-affairs capability-building seminar. [ 1 ]
- Yonhap reports in its bio roundup that the association will hold a global clinical R&D seminar on Oct 16 at its offices. [ 2 ]
- Seminar scheduled for Oct 16 at the association's offices, according to Yonhap. [ 2 ]